Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. (TN8)

Market Closed
23 Feb, 20:00
XMUN XMUN
432. 45
-5.05
-1.15%
- Market Cap
37.17 P/E Ratio
1.56% Div Yield
0 Volume
21.53 Eps
437.5
Previous Close
Day Range
432.45 432.45
Year Range
339.75 542.7
Want to track TN8 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TN8 earnings report is expected in 56 days (21 Apr 2026)

Summary

TN8 closed today lower at €432.45, a decrease of 1.15% from yesterday's close, completing a monthly decrease of -12.76% or €63.25. Over the past 12 months, TN8 stock lost -12.76%.
TN8 pays dividends to its shareholders, with the most recent payment made on Jan 15, 2026. The next estimated payment will be in In 1 month on Apr 15, 2026 for a total of €0.43.
The last earnings report, released on Jan 29, 2026, missed the consensus estimates by -6.45%. On average, the company has fell short of earnings expectations by -3.98%, based on the last three reports. The next scheduled earnings report is due on Apr 21, 2026.
Thermo Fisher Scientific Inc. has completed 6 stock splits, with the recent split occurring on Jun 06, 1996.
The company's stock is traded on 13 different exchanges and in various currencies, with the primary listing on NYSE (USD).

TN8 Chart

Thermo Fisher: The Market Is Missing The Point, This Pullback Is A Buy (Rating Update)

Thermo Fisher: The Market Is Missing The Point, This Pullback Is A Buy (Rating Update)

Thermo Fisher delivered strong Q1 results, beating expectations with revenue of $12.21B (+7% YoY) and EPS of $6.57 (+8%). I reaffirm my strong buy rating on TMO, setting a target price of $668 per share, citing resilient margins and competitive positioning. TMO's 2026 guidance calls for $46.3B-$47.2B revenue (+4-6%) and EPS of $24.22-$24.80 (+6-8%), with organic growth of 4%.

Seekingalpha | 3 weeks ago
Thermo Fisher Scientific Inc. (TMO) Q4 2025 Earnings Call Transcript

Thermo Fisher Scientific Inc. (TMO) Q4 2025 Earnings Call Transcript

Thermo Fisher Scientific Inc. (TMO) Q4 2025 Earnings Call Transcript

Seekingalpha | 3 weeks ago
Thermo Fisher stock slides on cautious profit guidance

Thermo Fisher stock slides on cautious profit guidance

Thermo Fisher Scientific Inc (NYSE:TMO, XETRA:TN8) delivered a fourth quarter earnings beat, but its shares moved lower as investors focused on margin pressures and cautious earnings guidance for 2026. The life sciences tools and diagnostics company guided 2026 revenue to a range of $46.3 billion to $47.2 billion, implying 4% to 6% growth and organic growth of 3% to 4%, broadly in line with consensus expectations and indicating continued modest demand across biopharma and life sciences end markets.

Proactiveinvestors | 3 weeks ago

Thermo Fisher Scientific Inc. (TN8) FAQ

What is the stock price today?

The current price is €432.45.

On which exchange is it traded?

Thermo Fisher Scientific Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is TN8.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.56%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Apr 21, 2026.

Has Thermo Fisher Scientific Inc. ever had a stock split?

Thermo Fisher Scientific Inc. had 6 splits and the recent split was on Jun 06, 1996.

Thermo Fisher Scientific Inc. Profile

Professional Services Industry
Industrials Sector
Marc N. Casper CEO
XMUN Exchange
US8835561023 ISIN
US Country
125,000 Employees
15 Dec 2025 Last Dividend
6 Jun 1996 Last Split
13 Jan 1978 IPO Date

Overview

Thermo Fisher Scientific Inc. is a global leader in serving science, offering a wide range of products and services across life sciences, analytical instruments, specialty diagnostics, and laboratory products, as well as biopharma services. The company boasts a broad presence, serving customers in North America, Europe, the Asia-Pacific region, and internationally. Its offerings are designed to cater to the needs of the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. By delivering solutions that support research and development, diagnostics, and the production of drugs and vaccines, Thermo Fisher Scientific plays a pivotal role in advancing public health and scientific endeavors worldwide. Founded in 1956, the company is headquartered in Waltham, Massachusetts.

Products and Services

  • Life Sciences Solutions

    This segment provides a variety of reagents, instruments, and consumables used in biological and medical research, the discovery and production of drugs and vaccines, and the diagnosis of infections and diseases. The offerings encompass biosciences, genetic sciences, and bio production and are tailored for markets including pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government sectors.

  • Analytical Instruments

    Includes instruments, consumables, software, and services suited for a wide range of applications in the pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. These instruments and services facilitate complex analyses and experiments.

  • Specialty Diagnostics

    This segment offers a variety of diagnostic products and services, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments. It covers the needs of the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; provides human leukocyte antigen typing and testing for the organ transplant market; and supplies healthcare products.

  • Laboratory Products and Biopharma Services

    Provides an extensive array of laboratory products and services, including research and safety market channel and pharma services and clinical research, catering to various scientific needs. The segment supports the research, development, and production processes across the scientific community.

The company offers these products and services through a combined approach of a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon and PPD brands.

Contact Information

Address: 168 Third Avenue
Phone: 781 622 1000